Optimizing Outcomes in Head and Neck Surgery
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Surgery".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 2044
Special Issue Editors
2. Craiova Emergency Clinic Districtual Hospital, Craiova, Romania
Interests: head and neck pathology; rhinology; rhinosinusitis with polyposis; otology; multidisciplinary approach in ENT
2. Bucharest Emergency University Hospital, Bucharest, Romania
Interests: head and neck surgery; oncology; salivary glands; trauma; rhinology; respiratory allergy; artificial intelligence; multidisciplinary approach in ENT
Special Issue Information
Dear Colleagues,
In otolaryngology and head and neck surgery, the goal of the diagnostic and therapeutic approach is to achieve a good physical and functional outcome. Functional surgery in ENT pathology aims, as appropriate, to restore hearing, nasal permeability, and smell. Cochlear implants in children and adults made huge progress in restoring hearing. Oncological surgery of the head and neck through the ablative time aims at a resection with negative margins of tumors of the pharynx, larynx, or cervical tumors. Alternatively, through reconstructive time, the aim is to restore some fundamental functional elements, such as anatomical breathing, swallowing, and phonation. Improving functional prognosis in head and neck surgery is an essential goal of clinical and research activity.
New techniques and technologies allow for less invasive approaches, an exploration of hidden areas (e.g., infratemporal fossa, anterior base of the skull), and more precise control of safety margins, enabling for the functional result of the surgical intervention to be as close as possible in appearance before the onset of the disease.
In head and neck cancers, new molecular biology diagnostic techniques allow for the refinement of diagnosis with the de-escalation of adjuvant oncological treatment and improved functional prognosis in terms of sequelae at the end of treatment. It should be remembered that in head and neck oncology, outcomes are measured by two major parameters: survival and quality of life. Neoadjuvant therapies, which include immunotherapy, allow less aggressive oncological surgery and, implicitly, a better functional outcome. Immunotherapy represents an exponentially developed alternative in the recent decade, offering high survival rates in unresectable recurrent and metastatic disease.
Biological therapies represent a horizon of significant improvement of the outcome in chronic rhinosinusitis with nasal polyposis, significantly improving the results obtained with endoscopic rhinosinusal surgery and corticosteroids. In recent years, artificial intelligence systems have been applied in the early diagnosis of head and neck cancer, as well as in personalized therapies.
We are pleased to invite you to contribute to this new Special Issue with manuscripts reflecting new directions in optimizing outcomes in otorhinolaryngology and head and neck surgery. We welcome original articles, but also reviews and selected rare case series, with the goal of updating our knowledge on this topic. We invite senior researchers to submit manuscripts, as well as young doctoral students with perspective research in head and neck surgery. Lastly, the Special Issue Mentor Program is designed to support early career researchers, including postdocs and new faculty members, by offering them the opportunity to propose innovative ideas for this Special Issue, titled “Optimizing Outcomes in Head and Neck Surgery”.
Dr. Carmen Aurelia Mogoantă
Guest Editor
Dr. Daniela Vrinceanu
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- head and neck
- surgery
- oncology
- outcomes
- artificial intelligence
- otology
- biologics
- immunotherapy
- multidisciplinary approach
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
